EMR|Analyst Targets
EMR|Company Info
EMR|Insider Trading
EMR|Fundamentals
EMR|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $1.85 | - | - |
| Q3'26 | $1.69 | $1.71 | +1.0% |
| Q2'26 | $1.53 | $1.54 | +0.4% |
| Q3'25 | $1.62 | $1.62 | +0.3% |
| Q2'25 | $1.51 | $1.52 | +0.7% |
| Q1'25 | $1.41 | $1.48 | +4.6% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $5.2B | - | - |
| Q3'26 | $4.9B | $4.9B | +0.5% |
| Q2'26 | $4.6B | $4.6B | -0.7% |
| Q3'25 | - | $4.9B | - |
| Q2'25 | - | $4.6B | - |
| Q1'25 | - | $4.4B | - |
EMR|Monthly Returns
Market Data
EMR Stock Snapshot
- Market cap
- 90.77B
- P/E ratio
- 35.2
- Day range
- $159.25 – $164.00
- News sentiment
- 47/100 · Neutral
- Analyst target
- $174.54 (+8.4%)
- Consensus
- Buy · 35 analysts
Momentum has flattened on EMR, leaving the next move dependent on news rather than the chart. The stock is liquid enough that positioning changes get absorbed without distorting the trend.
Reverse DCF
What growth is priced into EMR?
At today's price, Emerson Electric Co. needs to grow free cash flow about 28.4% a year for the next 10 years to justify its valuation at a 10.42% cost of capital. Over its actual history it has compounded free cash flow at -3.3% a year, so the market is asking for 31.7 percentage points above its own delivered rate. On that basis EMR looks priced above what its own growth record supports.
- Implied FCF growth
- 28.4%
- Historical FCF CAGR
- -3.3%
- Growth gap
- +31.7 pts
- Verdict
- RICH
- Discount rate (WACC)
- 10.42%
- Beta
- 1.22
Behaviour On Record
What EMR's own history says about today's numbers
- Realized volatility (21d)
- 19.6% 31st pct
- Below its peak
- -0.2%
- vs 200-day average
- +12.7%
- Up days (1y)
- 53%
Emerson Electric Co. is currently running 19.6% annualised volatility over the last 21 sessions. Measured against EMR's own 13 years of daily returns rather than a market-wide average, that is the 31st percentile — on the quiet side for this stock, against a typical reading of 23.4%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
EMR is at its running peak. Across 12 full years on file its median worst-drawdown-in-a-year was -21.8%, with the deepest at -51.1% in 2020 — so highs have historically been given back before they were extended.
Price sits +12.7% from its 200-day moving average. Against every other day in its history, that gap ranks at the 84th percentile — a wider gap than this stock usually carries. Over the past year EMR closed higher on 53% of sessions, and it is currently 4 sessions into a rising streak.
On October specifically: over 14 years of records, EMR finished the month higher 10 of 14 times, with a median return of +2.7% and an average of +2.0%. Its strongest month historically has been November at +3.4% on average, its weakest March at -1.8%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: EMR has opened more than 2% away from the prior close in 119 of 3,268 sessions (3.6% of the time), with the largest gaps running +8.8% and -10.3%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 3,269 daily closes between 2013-10-15 and 2026-10-14, split-adjusted, recomputed daily. Percentiles are against EMR's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of EMR's sector?
Emerson Electric Co. sits in the Industrials sector, currently ranked 8th of 12 GICS sectors by relative-strength rotation score (improving).
- Sector rank
- #8 of 12
- Sector state
- Improving
- Sector rotation score
- 36
Analyst Rating Changes
Are analysts turning bullish or bearish on EMR?
RBC Capital most recently reiterated its rating on Emerson Electric Co. to Outperform on Oct 14, 2026 with a price target of $188 (from $179). Over the last 90 days, coverage has run 1 upgrade against 0 downgrades, a net bullish lean.
- Latest action
- RBC Capital — Outperform
- 90-day upgrades
- 1
- 90-day downgrades
- 0
- Net rating momentum
- +1
Earnings Release, Scored
What did Emerson Electric Co.'s latest earnings release say?
Most important lines
- 1
Karsanbhai continued, "We are raising our full year guidance, reflecting our strong third quarter performance and healthy demand.
Guidance raised - 2
"Demand was robust, with underlying orders up 7%, led by Software & Systems and broad-based growth in North America and Asia.
- 3
As we pivot capital allocation to returning cash to shareholders, the 2026 outlook assumes returning ~$2.2B through ~$1B share repurchases and ~$1.2B of dividends.
Peers & ETF holders
EMR peers & ETF holders
Specialty Industrial MachineryMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▲ Buy | 54,909,180 | 9.92% | $7.29B | 2026-01-29 |
| BlackRock, Inc. | ▲ Buy | 43,265,282 | 7.82% | $6.19B | 2026-08-07 |
| Bank of America Corp | ▼ Sell | 18,366,373 | 3.32% | $2.63B | 2026-08-14 |
| Geode Capital Management, LLC | ▲ Buy | 12,613,008 | 2.28% | $1.80B | 2026-08-12 |
| Morgan Stanley | ▲ Buy | 12,010,701 | 2.17% | $1.72B | 2026-08-13 |
| JPMorgan Chase & Co | ▼ Sell | 10,753,147 | 1.94% | $1.54B | 2026-08-12 |
| Wells Fargo & Company | ▼ Sell | 9,761,725 | 1.76% | $1.40B | 2026-08-14 |
| Fisher Asset Management, LLC | ▲ Buy | 9,426,709 | 1.70% | $1.35B | 2026-08-04 |
| Wellington Management Group LLP | ▼ Sell | 8,464,091 | 1.53% | $1.21B | 2026-08-14 |
| Norges Bank | ▼ Sell | 7,512,591 | 1.36% | $1.08B | 2026-08-12 |
| Invesco Ltd. | ▼ Sell | 6,978,387 | 1.26% | $998.96M | 2026-08-14 |
| Northern Trust Corp | ▼ Sell | 6,127,385 | 1.11% | $877.14M | 2026-08-13 |
| Goldman Sachs Group Inc | ▲ Buy | 4,849,579 | 0.88% | $694.22M | 2026-08-14 |
| FMR LLC (Fidelity) | ▼ Sell | 4,041,677 | 0.73% | $578.57M | 2026-08-13 |
| Janus Henderson Group plc | ▲ Buy | 2,207,707 | 0.40% | $289.26M | 2026-05-18 |
| AllianceBernstein L.P. | ▼ Sell | 1,235,094 | 0.22% | $161.82M | 2026-08-14 |
| Neuberger Berman Group LLC | ▲ Buy | 790,542 | 0.14% | $113.17M | 2026-08-13 |
| D. E. Shaw & Co., Inc. | ▲ Buy | 728,223 | 0.13% | $104.25M | 2026-08-14 |
| Citigroup Inc | ▲ Buy | 720,454 | 0.13% | $103.13M | 2026-08-03 |
| Point72 Asset Management, L.P. | ▲ Buy | 557,706 | 0.10% | $79.84M | 2026-08-14 |
| Citadel Advisors LLC | ▼ Sell | 453,070 | 0.08% | $64.86M | 2026-09-02 |
| Adage Capital Partners GP, L.L.C. | ▼ Sell | 406,923 | 0.07% | $58.25M | 2026-08-14 |
| Marshall Wace, LLP | ▼ Sell | 279,107 | 0.05% | $39.95M | 2026-08-13 |
| Prudential Financial Inc | ▼ Sell | 276,513 | 0.05% | $39.58M | 2026-08-12 |
| AQR Capital Management LLC | ▲ Buy | 208,508 | 0.04% | $29.72M | 2026-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Kevin Hern | House | OK01 | ▼ Sell | $1K - $15K | 2026-09-14 | 2026-09-25 |
| Richard Dean Dr McCormick | House | GA06 | ▼ Sell | $1K - $15K | 2026-07-30 | 2026-08-14 |
| Alan Armstrong | Senate | OK | ▲ Buy | $1K - $15K | 2026-03-27 | 2026-07-21 |
| Richard Dean Dr McCormick | House | GA06 | ▲ Buy | $1K - $15K | 2025-11-05 | 2025-12-09 |
| Valerie Hoyle | House | OR04 | ▼ Sell | $1K - $15K | 2025-09-23 | 2025-10-10 |
| Valerie Hoyle | House | OR04 | ▲ Buy | $1K - $15K | 2025-07-14 | 2025-09-12 |
| Ritchie John Torres | House | NY15 | ▼ Sell | $1K - $15K | 2025-07-11 | 2025-08-20 |
| Rob Bresnahan | House | PA08 | ▼ Sell | $1K - $15K | 2025-04-08 | 2025-04-28 |
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-03-12 | 2025-08-13 |
| Bruce Westerman | House | AR04 | ▲ Buy | $1K - $15K | 2025-03-03 | 2025-04-16 |
| Rob Bresnahan | House | PA08 | ▲ Buy | $1K - $15K | 2025-02-25 | 2025-03-27 |
| Lisa McClain | House | MI09 | ▲ Buy | $1K - $15K | 2025-02-05 | 2025-08-13 |
| Pete Ricketts | Senate | NE | ▼ Sell | $100K - $250K | 2023-09-21 | 2023-10-20 |
| Richard Dean Dr McCormick | House | GA06 | ▲ Buy | $1K - $15K | 2023-03-15 | 2025-09-17 |
| Bill Cassidy | Senate | LA | ▼ Sell | $1K - $15K | 2020-03-09 | 2020-03-27 |
| Shelley Moore Capito | Senate | WV | ▲ Buy | $1K - $15K | 2018-04-24 | 2019-05-09 |
| Bill Cassidy | Senate | LA | ▼ Sell | $1K - $15K | 2018-04-23 | 2018-05-15 |
| Shelley Moore Capito | Senate | WV | ▲ Buy | $1K - $15K | 2018-04-05 | 2019-05-09 |
| John F. Reed | Senate | RI | ▼ Sell | $1K - $15K | 2017-01-30 | 2017-02-21 |
| Bill Cassidy | Senate | LA | ▲ Buy | $1K - $15K | 2016-03-31 | 2017-12-06 |
| Gary Peters | Senate | MI | ▲ Buy | $1K - $15K | 2015-04-14 | 2015-05-06 |
| Sheldon Whitehouse | Senate | RI | ▼ Sell | $1K - $15K | 2014-07-10 | 2014-07-17 |
| Sheldon Whitehouse | Senate | RI | ▼ Sell | $1K - $15K | 2014-02-10 | 2014-02-27 |